CCN2 and systemic sclerosis: Our study demonstrated that, similar to dermal fibroblasts, ciprofloxacin has antifibrotic effects on cultured SSc ILD lung fibroblasts, by upregulating Fli1 and MMP1 levels and downregulating collagen type I and CCN2 gene expression.